These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 9285936

  • 1. Full and partial agonist activity of C-terminal cholecystokinin peptides at the cloned human CCK-A receptor expressed in Chinese hamster ovary cells.
    Dunlop J, Zhang Y, Evans N.
    Peptides; 1997; 18(6):865-8. PubMed ID: 9285936
    [Abstract] [Full Text] [Related]

  • 2. SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
    Bignon E, Bachy A, Boigegrain R, Brodin R, Cottineau M, Gully D, Herbert JM, Keane P, Labie C, Molimard JC, Olliero D, Oury-Donat F, Petereau C, Prabonnaud V, Rockstroh MP, Schaeffer P, Servant O, Thurneyssen O, Soubrié P, Pascal M, Maffrand JP, Le Fur G.
    J Pharmacol Exp Ther; 1999 May; 289(2):742-51. PubMed ID: 10215648
    [Abstract] [Full Text] [Related]

  • 3. Are radioligand antagonist/agonist binding ratios in rat pancreas predictive of functional efficacy of cholecystokinin receptor agonists and antagonists?
    Patel S, Chapman KL, Smith AJ, Bailey I, Freedman SB.
    Regul Pept; 1996 Aug 27; 65(1):29-35. PubMed ID: 8876033
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological characterization of a Chinese hamster ovary cell line transfected with the human CCK-B receptor gene.
    Dunlop J, Brammer N, Ennis C.
    Neuropeptides; 1996 Aug 27; 30(4):359-63. PubMed ID: 8914862
    [Abstract] [Full Text] [Related]

  • 5. CCK antagonists interact with CCK-B receptors on human small cell lung cancer cells.
    Staley J, Jensen RT, Moody TW.
    Peptides; 1990 Aug 27; 11(5):1033-6. PubMed ID: 2178246
    [Abstract] [Full Text] [Related]

  • 6. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF, Wagenaar F, Nadzan AM.
    Mol Pharmacol; 1989 Dec 27; 36(6):881-6. PubMed ID: 2601685
    [Abstract] [Full Text] [Related]

  • 7. Combined dose-ratio analysis of cholecystokinin receptor antagonists, devazepide, lorglumide and loxiglumide in the guinea-pig gall bladder.
    Bishop LA, Gerskowitch VP, Hull RA, Shankley NP, Black JW.
    Br J Pharmacol; 1992 May 27; 106(1):61-6. PubMed ID: 1504732
    [Abstract] [Full Text] [Related]

  • 8. Mutational analysis of the putative devazepide binding site of the CCK(A) receptor.
    Smeets RL, IJzerman AP, Hermsen HP, Ophorst OJ, Van Emst-de Vries SE, De Pont JJ, Willems PH.
    Eur J Pharmacol; 1997 Apr 23; 325(1):93-9. PubMed ID: 9151944
    [Abstract] [Full Text] [Related]

  • 9. CCK-B receptor-mediated stimulation of polyphosphoinositide turnover in GH3 pituitary cells in response to cholecystokinin and pentagastrin.
    Smith AJ, Freedman SB.
    Life Sci; 1996 Apr 23; 58(11):883-95. PubMed ID: 8786694
    [Abstract] [Full Text] [Related]

  • 10. Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry.
    Reum T, Schäfer U, Marsden CA, Fink H, Morgenstern R.
    Neuropeptides; 1997 Feb 23; 31(1):82-8. PubMed ID: 9574843
    [Abstract] [Full Text] [Related]

  • 11. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
    Smeets RL, Fouraux MA, van Emst-de Vries SE, De Pont JJ, Willems PH.
    Br J Pharmacol; 1998 Mar 23; 123(6):1189-97. PubMed ID: 9559904
    [Abstract] [Full Text] [Related]

  • 12. Contrasting roles of leu(356) in the human CCK(1) receptor for antagonist SR 27897 and agonist SR 146131 binding.
    Gouldson P, Legoux P, Carillon C, Delpech B, Le Fur G, Ferrara P, Shire D.
    Eur J Pharmacol; 1999 Nov 03; 383(3):339-46. PubMed ID: 10594328
    [Abstract] [Full Text] [Related]

  • 13. Characterization of CCKA receptor mediated pepsinogen secretion in porcine chief cells.
    Meyer G, Beinborn M, Sewing KF.
    Pharmacology; 1996 Jul 03; 53(1):48-59. PubMed ID: 8875601
    [Abstract] [Full Text] [Related]

  • 14. Synergistic interactions between human transfected adenosine A1 receptors and endogenous cholecystokinin receptors in CHO cells.
    Dickenson JM, Hill SJ.
    Eur J Pharmacol; 1996 Apr 29; 302(1-3):141-51. PubMed ID: 8791002
    [Abstract] [Full Text] [Related]

  • 15. CCK antagonists reveal that CCK-8 and JMV-180 interact with different sites on the rat pancreatic acinar cell CCKA receptor.
    Yule DI, Williams JA.
    Peptides; 1994 Apr 29; 15(6):1045-51. PubMed ID: 7527529
    [Abstract] [Full Text] [Related]

  • 16. Cholecystokinin increases intracellular Ca2+ concentration in the Human JURKAT T Lymphocyte cell line.
    Lignon MF, Bernad N, Martinez J.
    Eur J Pharmacol; 1993 May 15; 245(3):241-6. PubMed ID: 8335062
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological studies on CCKB receptors in guinea pig synaptoneurosomes.
    Galas MC, Bernad N, Martinez J.
    Eur J Pharmacol; 1992 May 12; 226(1):35-41. PubMed ID: 1327841
    [Abstract] [Full Text] [Related]

  • 18. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
    Smeets RL, Fouraux MA, Pouwels W, van Emst-de Vries SE, Ronken E, De Pont JJ, Willems PH.
    Br J Pharmacol; 1998 Jul 12; 124(5):935-45. PubMed ID: 9692779
    [Abstract] [Full Text] [Related]

  • 19. Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin.
    Kennedy K, Gigoux V, Escrieut C, Maigret B, Martinez J, Moroder L, Fréhel D, Gully D, Vaysse N, Fourmy D.
    J Biol Chem; 1997 Jan 31; 272(5):2920-6. PubMed ID: 9006937
    [Abstract] [Full Text] [Related]

  • 20. Characterization of CCK receptors in a novel smooth muscle preparation from the guinea-pig stomach by use of the selective antagonists CI-988, L-365,260 and devazepide.
    Boyle SJ, Tang KW, Woodruff GN, McKnight AT.
    Br J Pharmacol; 1993 Aug 31; 109(4):913-7. PubMed ID: 8401944
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.